Catalyst Pharmaceuticals, Inc. Announces Proposed Public
CORAL GABLES, Fla., Jan. 04, 2024 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. (“Catalyst” or the “Company”) (Nasdaq: CPRX) announced today that it...
Stay updated with breaking news from Lambert Eaton. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
CORAL GABLES, Fla., Jan. 04, 2024 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. (“Catalyst” or the “Company”) (Nasdaq: CPRX) announced today that it...
CORAL GABLES, Fla., Jan. 05, 2024 -- Catalyst Pharmaceuticals, Inc. announced today the pricing of an underwritten public offering of 10,000,000 shares of its common stock at a public offering...
CORAL GABLES, Fla., Jan. 04, 2024 -- Catalyst Pharmaceuticals, Inc. announced today that it has commenced an underwritten public offering of $150,000,000 of its common stock. Catalyst also...
Catalyst Ranked #4 on the ListCORAL GABLES, Fla., Dec. 05, 2023 -- Catalyst Pharmaceuticals, Inc. today announced its inclusion in Forbes' esteemed list of America's Most Successful Small-Cap...
Ms. Alicia Grande, Catalyst's Current CFO, to Retire at the End of 2023 Dr. Steven Miller Promoted to Executive Vice President, Chief Operating and Scientific Officer and Jeffrey Del Carmen Promoted...